Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on November 13, 2015, to report a change in its Board of Directors. Robert A. Ingram resigned from his position as a Director and member of the Compensation Committee, effective November 10, 2015. The company stated that Mr. Ingram's resignation was due to demands from his other business activities and not a result of any disagreement with Regeneron's operations, policies, or practices.
Key Highlights
- 1Robert A. Ingram has resigned from Regeneron's Board of Directors.
- 2Mr. Ingram also resigned from the Compensation Committee of the Board.
- 3The resignation was effective November 10, 2015.
- 4The reason cited for resignation is increased demands from other business activities.
- 5Regeneron stated there were no disagreements with Mr. Ingram regarding the company's operations, policies, or practices.
Frequently Asked Questions
Robert A. Ingram resigned from the Board of Directors of Regeneron Pharmaceuticals, Inc.
The resignation of Robert A. Ingram was effective as of November 10, 2015.
The company stated that Mr. Ingram resigned due to demands related to his other business activities.
No, Regeneron explicitly stated that Mr. Ingram's resignation was not due to any disagreement with the Company on any matter relating to Regeneron's operations, policies, or practices.